According to the report by Allied Market Research, titled, "Drug Screening Market by Product & Services [Equipment (Immunoassay Analyzers, Chromatography Instruments, and Breath Analyzers {Semiconductor Breath Analyzers and Fuel Cell Analyzers}, Rapid Testing Devices(RTD) {Oral Fluid Testing Devices and Urine Testing Devices}), Consumables {Assay Kits, Calibrators & Controls, and Sample Collection Cups} and Laboratory Services], by Sample Type [Oral Fluid/Saliva, Breath, Hair and Other Samples {Blood & Sweat}], and by End User [Workplace & Schools, Criminal Justice Systems & Law Enforcement Agencies, Drug Testing Laboratories, Drug Treatment Centers, Hospitals, Personal Users, and Pain Management Centers] - Global Opportunity Analysis and Industry Forecast, 2017-2023". The report provides a detailed analysis of changing market dynamics, top segments, value chain, key investment pockets, regional scenario, and competitive landscape.

Global Drug Screening Market is expected to reach $9,447 million in 2023 from $5,214 million in 2016 registering a CAGR of 8.7%, during the forecast period, 2017-2023.

For Right Perspective and Competitive Insights, Get Sample Report at:

https://www.alliedmarketresearch.com/request-sample/1070

The increasing awareness regarding the ill effects of drug abuse along with the increased stringency of regulations to prohibit drug abuse is expected fuel the innovations and market growth.

Drug screening is carried out to detect the presence of any illegal drug in the different biological samples such as blood or urine. Biological samples derived from the subject are tested under drug screening devices to diagnose the nature and amount of drug in the system. Drug screening manufacturers provide a wide range of high-tech equipment which is used by organizations and law enforcement agencies to check the presence of any illegal drug in the body. Drug screening devices have helped government officials, employers and schools to maintain a drug free and healthy environment for individuals.

Key Findings of the Drug Screening Market:

• Under products & services equipment segment the rapid testing devices segment is projected to grow at the highest CAGR of 9.6% from 2017-2023 over the forecast period.
• Hair sample segment is poised to witness the fastest growth during the forecast period.
• Workplace and schools generated the highest revenue in 2016, and is expected to continue its dominance over the forecast period.
• North America dominated the global drug screening market over the analysis period, and is projected to grow at a CAGR of 8.1% from 2017-2023.
• Asia-Pacific drug screening market is an upcoming market and expected to generate new opportunities for market players.

The major companies in drug screening market include Alere, Inc., Drgerwerk AG & Co. KGAA, Abbott Laboratories, Hoffmann-La Roche AG, Biorad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific, Inc., Danaher Corporation, Quest Diagnostics Incorporated and Express Diagnostics International Inc.

Get detailed COVID-19 impact analysis@ Request For Customization:-

https://www.alliedmarketresearch.com/request-for-customization/1070

FREQUENTLY ASKED QUESTIONS?

Q1. What was the size of the global Drug Screening Market in 2017?Q2. How much will the global Drug Screening Market be worth in the future?Q3. What would be forecast period in the market report?Q4. What are the segments of Drug Screening Market?Q5. The global Drug Screening Market is segmented on the basis of product type, connectivity, distribution channel, and region.

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Tags: Drug Screening Market

See Campaign: https://www.alliedmarketresearch.com/Drug-Screening-marketContact Information:David Correa 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States Toll Free: 1-800-792-5285 UK: +44-845-528-1300 Hong Kong: +852-301-84916 India (Pune): +91-20-66346060 Fax: +1-855-550-5975 help@alliedmarketresearch.com Web: https://www.alliedmarketresearch.com Follow Us on: LinkedIn TwitterTags:Empirits, Healthfirsto, PR-Wirein, canadatousd, Reportedtimes, Menafn, Fexti, lebc, Dthai, Research Newswire, English